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The mazEF homologs of Staphylococcus aureus, designated mazEFsa, have been shown to cotranscribe with the
sigB operon under stress conditions. In this study, we showed that MazEFSa, as with their Escherichia coli
counterparts, compose a toxin-antitoxin module wherein MazFSa leads to rapid cell growth arrest and loss in
viable CFU upon overexpression. MazFSa is a novel sequence-specific endoribonuclease which cleaves mRNA
to inhibit protein synthesis. Using ctpA mRNA as the model substrate both in vitro and in vivo, we demon-
strated that MazFSa cleaves single-strand RNA preferentially at the 5 side of the first U or 3 side of the second
U residue within the consensus sequences VUUV (where V and V are A, C, or G and may or may not be
identical). Binding studies confirmed that the antitoxin MazESa binds MazFSa to form a complex to inhibit the
endoribonuclease activity of MazFSa. Contrary to the system in E. coli, exposure to selected antibiotics
augmented mazEFsa transcription, akin to what one would anticipate from the environmental stress response
of the sigB system. These data indicate that the mazEF system of S. aureus differs from the gram-negative
counterparts with respect to mRNA cleavage specificity and antibiotic stresses.
Many bacteria have chromosomally encoded toxin-antitoxin
(TA) loci, in which the toxin and antitoxin genes exist in an
operon and are coexpressed together to form a TA complex.
The toxin is stable, whereas the antitoxin is a labile protein
degraded in vivo by host proteases (e.g., Clp or Lon in Esch-
erichia coli). Under conditions that preclude the continuous
synthesis of the antitoxin, the toxin can exert its toxic effect to
inhibit cell growth (7, 9, 12). There are at least eight typical TA
families known in prokaryotes (12, 21). Among these, the
MazEF and RelBE systems from E. coli have been the most
extensively studied (7, 9, 12). Structural studies have disclosed
that the MazE-MazF complex in E. coli consists of two MazF
dimers and one MazE dimer in a hexameric MazF2-MazE2-
MazF2 configuration (17). In contrast, the RelBE complex
from Pyrococcus horikochi is a (RelE-RelB)2 tetramer (32).
Inhibition of protein synthesis by MazF in E. coli has been
found to be attributable to cleavage of cellular mRNA. More
specifically, MazF in E. coli is a sequence-specific endoribo-
nuclease, cleaving mRNA at ACA sites independently of ribo-
somes both in vitro and in vivo (6, 34). The cleavage occurs at
the 5 end of ACA sequence to yield a 2,3-cyclic phosphate as
part of the end product. The 2-OH group of the nucleotide
preceding the ACA sequence is essential for MazF cleavage
(37). In contrast, the RelE toxin of E. coli was found to cleave
mRNA positioned at the ribosomal A-site both in vitro and in
vivo (26). Cleavage occurs between the second and third bases
of the A-site codon (UAH, where H is usually G or A), with
the cleavage efficiency depending on the specific codon at the
ribosomal A-site. For instance, UAG and UAA are cleaved
more efficiently than the UGA stop codon (26). The toxin
systems from other prokaryotes also appeared to represent
sequence-specific endoribonucleases. The PemK toxin from
plasmid R100 in E. coli cleaves mRNA at UAH (where H is A,
C, or U) (36), and ChpBK cleaves at ACY (where Y is A, G,
or U) in a single-stranded RNA (38), while the Bacillus subtilis
MazF homolog EndoA cleaves mRNA at a UAC sequence
(27). Recently, two MazF homologs from Mycobacterium tu-
berculosis were also found to be endoribonucleases. One of the
MazF homologs from M. tuberculosis cleaves mRNA at UAC
triplets, while the other homolog cleaves U-rich regions within
mRNA (39).
In examining the sigB operon of Staphylococcus aureus, Kullik
et al. (18) noted that an open reading frame (ORF) imme-
diately upstream of the sigB operon may encode a mazF ho-
molog (designated the pemK homolog). Senn et al. (30)
subsequently demonstrated that the sigB operon in S. aureus
strain COL comprises two additional ORFs (SA2059 and
SA2058) in addition to rsbU, rsbV, rsbW, and sigB. They also
observed, as did Gertz et al. (13), that SA2058 and, to a much
lesser extent, SA2059 share some degree of homology with
MazF and MazE of E. coli, respectively. SA2059 and SA2058
are cotranscribed with the sigB operon under stress conditions,
such as heat and high-salt conditions (30). For brevity and
consistency, we propose to name SA2059 and SA2058 (desig-
nated as SA1873 and SAS067 in N315) in COL as MazESaand
MazFSa, respectively, in S. aureus. Although it has been hinted
that the S. aureus MazEFSa may act as a TA module (30), there
have been no experimental data supporting this hypothesis.
This confusion has been generated in part as a consequence of
a general lack of protein sequence similarity between MazESa
and its E. coli counterpart.
In this study, we provide definitive evidence that MazEFSa is
a TA module in S. aureus, with MazFSa as the toxin. Our data
demonstrate that MazFSa is a sequence-specific endoribo-
nuclease which cleaves ctpA mRNA at a consensus U-rich
sequence of VUUV (where V and V are A, C, or G and may
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or may not be identical) both in vivo and in vitro. MazFSa
showed high cellular toxicity in both E. coli and S. aureus upon
induction and inhibited protein synthesis in a cell-free system.
Collectively, our results suggest that the activated MazEFSa
TA module cleaves mRNA cleavage at a specific site under
stressful conditions to affect translation. This finding raises the
possibility that inhibition of MazESa may represent a novel
approach to antibacterial therapy for S. aureus.
MATERIALS AND METHODS
Bacterial strains and culture conditions. We used E. coli strains DH5 and
BL21(DE3)pLysS and S. aureus strains Newman and 178RI (8) for these studies.
S. aureus 178RI carries an isopropyl--D-thiogalactopyranoside (IPTG)-induc-
ible T7 polymerase gene integrated into the geh locus in the chromosome of
RN4220. For transduction, phage 85 was used to produce phage lysates of S.
aureus 178RI. The phage lysate was then used to infect S. aureus Newman as
described elsewhere (3) to obtain the S. aureus transductant ACL6094 carrying
the T7 polymerase gene integrated into the chromosome in the Newman back-
ground. Cultures were routinely grown in LB for E. coli and in 03GL or trypticase
soy broth for S. aureus with aeration at 37°C. The media were supplemented with
either ampicillin (Amp; 70 g/ml) or chloramphenicol (Cm; 10 g/ml).
Construction of plasmids. The mazESa (GenBank accession number Y16431)
and mazFSa (GenBank accession number Y07645) genes were amplified by PCR
using S. aureus Newman genomic DNA as a template and cloned into the NcoI
and BamHI sites of cloning vectors pCDF1 and pET14b (Novagen) in E. coli to
make pCDF1-MazE(His)6 and pET14b-MazF(His)6 with the His6 tag at the N
terminus, respectively. The mazEsa gene without the His tag was amplified by
PCR and cloned into the NdeI/XhoI sites of pETDuet1 (Novagen). An NcoI-
BamHI-digested DNA fragment from pET14b-MazF(His)6 was then inserted to
make pETDuet1-MazEF(His)6 with the His6 tag only at the MazFSa N terminus.
An NcoI-BamHI- and a BglII-EcoRI-digested DNA fragment from pET14b-
MazF(His)6 was further cloned into NcoI- and BamHI-digested pBAD22 (14)
and BglII-EcoRI-digested pG164 (8), respectively, to generate pBAD22-
MazF(His)6 and pG164-MazF(His)6. The ctpA gene (encoding a carboxy-termi-
nal protease from S. aureus; GenBank accession number NP_374534) was also
amplified by PCR using S. aureus Newman genomic DNA as the template and
cloned into the NcoI and BamHI sites of pET14b (Novagen) to produce
pET14b-ctpA. A BglII-EcoRI-digested fragment from pET14b-ctpA was further
cloned into BamHI- and EcoRI-digested pG164-MazF(His)6 to generate pG164-
MazF(His)6/ctpA. DNA techniques were performed according to standard pro-
cedures (28).
Protein expression and purification. MazE(His)6Sa was expressed in E. coli
BL21(DE3)pLysS carrying the plasmid pCDF1-MazE(His)6 under IPTG induc-
tion (1 mM) for 4 h. For MazF(His)6Sa expression, the MazESa and
MazF(His)6Sa genes were coexpressed in E. coli BL21(DE3)pLysS harboring
the plasmid pETDuet1-MazEF(His)6 after IPTG induction (1 mM) for 6 h. The
cells were harvested and subjected to lysis by ultrasonication. MazE(His)6Sa and
MazE-MazF(His)6Sa complex were purified with a nickel-nitrilotriacetic acid
resin affinity column (Novagen) according to the manufacturer’s protocol.
MazF(His)6Sa was further purified from the MazE-MazF(His)6Sa complex as
described previously (35). In brief, MazESa was dissociated from MazF(His)6Sa
in the purified MazE-MazF(His)6Sa complex with 6 M guanidine HCl.
MazF(His)6Sa was retrapped with the nickel-nitrilotriacetic acid resin affinity
column, eluted, and refolded by stepwise dialysis as described previously (25).
Native PAGE. Various amounts of MazE(His)6Sa and MazF(His)6Sa were
mixed in binding buffer (50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 1 mM dithio-
threitol, and 5% glycerol) at 4°C for 30 min and subjected to native polyacryl-
amide gel electrophoresis (PAGE) analysis in running buffer containing 82.6 mM
Tris-HCl (pH 9.4) and 33 mM glycine as described previously (35). The protein
bands were visualized by staining with Coomassie brilliant blue.
Primer extension analyses. For in vitro primer extension, the ctpA mRNA was
transcribed from BamHI-linearized pET14b-ctpA plasmid, using the T7 large-
scale transcription kit (Promega) according to the manufacturer’s protocol. Five
g of ctpA mRNA was partially digested with 15 pmol of MazFSa in a 20-l
reaction mixture containing 40 U of RNase inhibitor, 50 mM Tris-HCl (pH 8.0),
50 mM NaCl, and 1 mM dithiothreitol at 37°C for 90 min. The digestion mixture
was then extracted with phenol-chloroform followed by ethanol precipitation to
remove the proteins. Primer extension (Promega primer extension kit) analysis
of the digested mRNA was carried out with labeled primers pEa d(GCTTGAT
CAGTTTTGTTTAAACCAC), pEb d(TGACCATGCCATCAATTGCAGC),
pEc d(AGGACGAATGCCAGCACGTTCTGCTGG), and pEd d(CTTCACT
ACCT CGTTGAACAGTTA), following the manufacturer’s protocol. The prim-
ers were 5-end labeled with [-32P]ATP using T4 polynucleotide kinase. For in
vivo primer extension analysis of ctpA mRNA cleavage sites in E. coli, we isolated
total cellular RNA from E. coli BL21(DE3)pLysS cells harboring both pBAD22-
MazF(His)6 and pET14b-ctpA. Cultures were induced with 1 mM IPTG to
transcribe the ctpA mRNA for 30 min. MazFSa was then induced by adding
arabinose to a final concentration of 0.2%. For in vivo primer extension in S.
aureus, 178RI harboring pG164-MazF(His)6/ctpA was induced with 1 mM IPTG.
The ctpA mRNA was cotranscribed with the mazFSa mRNA. After induction,
total cellular RNA from a 10-ml culture was then extracted at the indicated time
point as described previously (4). Trace DNA was further removed by digestion
with RNase-free DNase I (Roche) followed by extraction with phenol-chloro-
form and ethanol precipitation to clean the RNA. Primer extension was then
carried out with different primers as described previously (16). The primer
extension product was analyzed on a 6% sequencing gel with the DNA sequenc-
ing ladder prepared with the same primer running side by side, followed by
autoradiography.
Cleavage of synthetic RNAs by MazFSa. All RNAs were commercially synthe-
sized (IDT, Coralville, IA) and 5-end labeled with [-32P]ATP using T4 polynu-
cleotide kinase. The native sequence, 5-UUGGCAAUUCAUAUCAAU-3,
corresponding to the sense RNA, was named AUUC, with AUUC as the target
cleavage site. Seven other RNA substrates with the center AUUC sequences
changed to AGUC, AUGC, AUUU, UUUC, AUUG, GUUC, and GUUG
sequences were also synthesized and named AGUC, AUGC, AUUU, UUUC,
AUUG, GUUC, and GUUG, respectively. The synthesized native DNA se-
quence, 5-TTGGCAATTCATATCAAT-3, named ATTC, was used as a con-
trol. A 19-base synthetic RNA (5-UGCAAUUCAUAUGAAUUGU-3) that
can form hairpin structure with the AUUC sequence located in the duplex region
was named RB-1. Another 19-base RNA (5-UGCAAUUCAUAUCAAUAU
G-3), which cannot form the hairpin structure, was named RB-2. An antisense
RNA to the native AUUC RNA sequence (5-AUUGAUAUGAAUUGCCA
A-3), was named RB-3. The labeled RNA substrates were digested with MazFSa
at 37°C for 30 min in a 10-l reaction mixture containing 20 U of RNase
inhibitor, 15 pmol of MazFSa, 1 pmol labeled RNA, and 10 mM Tris-HCl (pH
7.9). The formation of RNA-RNA duplex with the sense RNA AUUC and
RB-3-, the antisense RNA-, or MazFSa-mediated cleavage was analyzed as de-
scribed elsewhere (36). Briefly, 1 pmol of labeled sense RNA was annealed with
its antisense RNA in different ratio combinations and incubated with 15 pmol of
MazFSa at 37°C for 30 min. The reactions were stopped by adding loading buffer
and analyzed by separating on a 20% sequencing gel. The RNA ladder was
prepared by partial alkaline hydrolysis (Ambion) of the 5-end-labeled 18-base
sense RNA, AUUC, according to the manufacturer’s protocol.
Northern blot hybridization. Total RNA from S. aureus was prepared by using
a TRIzol isolation kit (Invitrogen, CA) and a reciprocating shaker (4). For
detection of specific transcripts, gel-purified DNA probes were radiolabeled with
[-32P]dCTP by use of a random-primed DNA labeling kit (Roche Diagnostics
GmbH) and hybridized under aqueous-phase conditions at 65°C. The blots were
subsequently washed with 2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate), 0.1% sodium dodecyl sulfate (SDS) twice at room temperature and 1
SSC, 0.1% SDS twice at 65°C and autoradiographed as previously described (20).
Bacterial viability assay. Bacteria were stained with the membrane-permeable
SYTO9 and the membrane-impermeable propidium iodide using the Live/Dead
BacLight bacterial viability kit (Molecular Probes, Eugene, OR) and quantitated
with fluorescence microplate readers according to the manufacturer’s protocol.
Bacteria with intact cell membranes stain fluorescent green, whereas bacteria
with damaged membranes stain fluorescent red.
RESULTS
MazEFSa is a TA module in S. aureus. A BLAST search of
SA2058, encoding a 120-residue protein in the COL genome,
identified this gene to have 20% identity and 40% similarity to
the E. coli MazF protein. The upstream gene SA2059, which is
cotranscribed with SA2058, encodes a 56-residue protein with
only 12% identity and 21% similarity to the E. coli MazE
protein. We have named SA2058 and SA2059 MazFSa
and MazESa for brevity and clarity, which were referred to
by Mittenhuber (21) as Orf136-s.a and Orf6-s.a (Fig. 1A).
To examine if MazFSa and MazESa function as a TA module,
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we determined whether the MazFSa protein, when expressed in-
dependently, is toxic to bacterial cells. For this purpose, the
mazFSa gene was cloned into the vector pBAD with an arabinose-
inducible promoter and the shuttle vector pG164 with an IPTG-
inducible promoter to generate pBAD-MazF(His)6 and pG164-
MazF(His)6, respectively, as described in Materials and Methods.
The growth of S. aureus ACL6094 carrying the plasmid pG164-
MazF(His)6 with a T7-dependent promoter was inhibited on
03GL agar plates supplemented with IPTG (1 mM) but not in the
unsupplemented control (Fig. 1B). Time course studies were fur-
ther carried out to characterize the toxicity of MazFSa. We found
that most of the cells with the mazFSa operon cloned into pG164
could not yield colonies on nutrient agar plates after induction for
60 min, while cells without induction showed normal growth (Fig.
1C). Although the CFU counts were reduced 99.5% after 60 min
postinduction, fewer than 5% of the cells stained positively with
propidium iodide (Molecular Probes, Eugene, OR), a dye which
binds membrane-compromised dead bacteria (data not shown),
thus indicating MazFSa expression mainly induced bacterial stasis
and hence a defect in replication. Similar results occurred in E.
coli with the plasmid pBAD-MazF(His)6 (data not shown). In
contrast, E. coli and S. aureus cells with mazEFSa cloned into
pBAD and pG164, respectively, exhibited normal growth even
under respective induction (arabinose or IPTG) (data not
shown). Together, these data demonstrated that MazFSa is toxic
to both E. coli and S. aureus and that this toxicity can be reversed
by coexpression of MazESa with MazFSa.
To further characterize the MazEFSa TA module, we ex-
pressed and purified MazF(His)6Sa and MazE(His)6Sa (both N-
terminally tagged) (Fig. 1D) in E. coli as described in Materials
and Methods. MazE(His)6Sa and MazF(His)6Sa were mixed to-
gether in a dose-dependent manner and subjected to native
PAGE analysis. Despite the noticed migration of MazE(His)6Sa
(pI 4.2), no obvious mobility was observed for MazF(His)6Sa
alone (Fig. 1E, lane 2), presumably due to its basic pI (9.5), which
approaches the pH (9.4) of the running buffer used in native
PAGE. Nevertheless, the MazEFSa complex, appearing as a high-
er-molecular-weight species than that of MazE(His)6Sa alone, was
observed at the top of the gel (Fig. 1E, lanes 3 to 5). The quantity
of the MazEFSa complex rose with increasing concentrations of
MazF(His)6Sa, while the amount of free MazE(His)6Sa at the
bottom of the gel continued to diminish (Fig. 1E). These
results indicated that MazESa and MazFSa, as a paired TA
module, interact in vitro and possibly in vivo.
MazFSa inhibits protein synthesis in a cell-free system. We
then examined the effect of the purified MazFSa on protein syn-
FIG. 1. Inhibition of cell growth by S. aureus MazFSa. (A) Schematic representation of genetic organization of the S. aureus mazEFSa and sigB
operons. (B) S. aureus ACL6094 cells were transformed with pG164-MazF(His)6. The cells were then streaked on a 03GL agar plate with or without
induction with IPTG (1 mM) followed by incubation overnight at 37°C. (C) Reduction of CFU with S. aureus ACL6094 harboring pG164-MazF(His)6
under induction. The cultures were induced at an optical density at 650 nm of 0.4 with IPTG (1 mM). To determine the CFU, samples were withdrawn
at various time points, spread on TSA plates supplemented with chloramphenicol (10 g/ml), and incubated at 37°C overnight. (D) Characterization of
MazESa/MazFSa. The MazE(His)6Sa and MazF(His)6Sa proteins were purified as described in Materials and Methods. The proteins were analyzed by 16%
SDS-PAGE. (i) lane 1, protein molecular mass markers; lane 2, MazE(His)6Sa; lane 3, MazF(His)6Sa; (ii) lane 4, purified MazE-MazF(His)6Sa complex.
The upper band is MazF(His)6Sa, and the lower band is the copurified MazESa. (E) Native PAGE analysis of MazEFSa complex formation. MazE(His)6Sa
was mixed with MazF(His)6Sa as described in Materials and Methods and subjected to native PAGE analysis. Lane M, molecular mass markers; lane 1,
MazE(His)6Sa (32 pmol); lane 2, MazF(His)6Sa (30 pmol); lanes 3 to 5, MazE(His)6Sa (32 pmol). Samples were mixed with 7.5 pmol, 15 pmol, and 30
pmol of MazF(His)6Sa, respectively. The MazESa/MazFSa complex is indicated by the arrow.
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thesis in a cell-free system. The synthesis of the truncated CtpA
protein (	15 kDa), representing part of the carboxy-terminal
protease from S. aureus, from the plasmid pET14b-ctpA was
carried out at 37°C for 1 h using an E. coli T7 S30 extract system
with and without MazFSa (Fig. 2A). The synthesis of CtpA was
inhibited with increasing concentrations of MazFSa and was al-
most completely blocked with 30 pmol added (Fig. 2A). Addition
of MazESa to the cell-free system containing MazFSa rescued
CtpA synthesis in a dose-dependent manner (Fig. 2B). As ex-
pected, the MazFSa protein also inhibited the synthesis of -lac-
tamase from the bla gene present in the pET14b-ctpA vector in E.
coli (Fig. 2). Preincubation of the E. coli cell-free protein synthesis
system with MazFSa for 20 min at 37°C prior to adding the plas-
mid pET14b-ctpA and MazESa did not have any significant effect
on subsequent CtpA synthesis (data not shown). These results
suggest that the primary target for MazFSa is not the ribosome,
tRNA, or other factors required for protein synthesis in this
system, but rather the mRNA of the cell.
In vitro cleavage of ctpA mRNA by MazFSa. To determine
whether MazFSa has endoribonuclease activity, we prepared
the ctpA mRNA using an in vitro transcription system as de-
scribed in Materials and Methods. The ctpA mRNA was then
incubated with MazFSa in a dose- and time-dependent manner.
As shown in Fig. 3A, the ctpA mRNA was cleaved into small
fragments with 15 pmol of MazFSa in a time-dependent man-
ner, while the addition of MazESa inhibited the digestion of
ctpA mRNA by MazFSa in a dose-dependent fashion (Fig. 3B).
These results demonstrate that MazFSa is an endoribonuclease
that cleaves mRNA to inhibit protein synthesis and that MazESa
functions as an antitoxin to counteract the endoribonuclease
activity of MazFSa.
The ctpA mRNA was noted to be cleaved into distinct, but
not smearing, bands by MazFSa (Fig. 3A), indicating that
MazFSa may be a sequence-specific endoribonuclease. To fur-
ther map the cleavage site, we employed MazFSa to partially
digest the ctpA mRNA and then subjected the digest to primer
extension, using four different DNA primers, pEa to -d, cov-
ering the experimental ctpA mRNA as described in Materials
and Methods. To determine the cleavage sites, each primer
extension product was analyzed on a 6% sequencing gel with a
DNA sequencing ladder prepared with the same primer (Fig.
4). The cleavage sites in the ctpA mRNA as determined by
primer extension studies are shown in Table 1. Cleavages oc-
curred preferentially in a U-rich region with a consensus se-
quence of VUUV in ctpA mRNA. The UU dinucleotides were
found to be conserved among all cleavage sites. However, the
FIG. 2. Effects of MazFSa and MazESa on cell-free protein synthesis.
(A) Inhibition of protein synthesis by MazFSa. Protein synthesis was car-
ried out with the plasmid pET14b-ctpA in an E. coli T7 S30 extract system
at 37°C for 1 h. Lane 1, control without MazFSa; lanes 2 to 6, various
amounts of MazFSa were added at 3.75 pmol, 7.5 pmol, 11.25 pmol, 15
pmol, and 30 pmol, respectively. (B) Protein synthesis was rescued by the
addition of MazESa. Lane 1, control without MazFSa; lane 2, 15 pmol of
MazFSa; lanes 3 to 6, 8 pmol, 16 pmol, 32 pmol, or 64 pmol of MazESa,
respectively, was added together with 15 pmol of MazFSa. The synthesis of
-lactamase and CtpA are indicated by arrows.
FIG. 3. Endoribonuclease activity of MazFSa. Five g of ctpA
mRNA was digested with 15 pmol of MazFSa as described in Materials
and Methods. (A) Cleavage of ctpA mRNA by MazFSa. Lane 1, control
without MazFSa; lanes 2 to 4, mRNA substrates were digested for 60
min, 90 min, and 120 min, respectively. (B) Inhibition of cleavage with
the addition of MazESa. Lane 1, mRNA with MazFSa; lanes 2 to 4,
mRNA substrates digested by MazFSa together with 4 pmol, 8 pmol, or
16 pmol of MazESa; lane 5, mRNA with 32 pmol of MazESa.
FIG. 4. In vitro primer extension analysis of the MazFSa cleavage
sites in ctpA mRNA. Primer extension was carried out as described in
Materials and Methods. Each primer extension product was analyzed
on a 6% sequencing gel with the DNA sequencing ladder prepared
with the same primer. (A and B) Cleavage sites in ctpA mRNA de-
tected with the primer pEa. (C and D) Cleavage sites in ctpA mRNA
detected with the primer pEb. The RNA sequences complementary to
the DNA sequence ladder are shown to the right of each figure, and
corresponding cleavage sites are indicated by arrows.
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primary cleavages occur at either 5 side of the first U or 3 side
of the second U residue in the VUUV sequence, with most
cleavages taking place 3 of the second U residue (Fig. 4; Table
1). However, not all of the VUUV sequences in the ctpA
mRNA were cleaved by MazFSa.
Cleavage specificity of MazFSa. To further define the spec-
ificity of cleavage sites, an 18-base synthetic RNA (5-UUGG
CAAUUCAUAUCAAU-3) with the AUUC sequence in the
center was used for digestion with MazFSa. A clear cleavage
was shown between the A and U of the sequence (Fig. 5A).
FIG. 5. Cleavage of synthetic RNA by MazFSa. All RNA substrates labeled at the 5 end with [-
32P]ATP were digested with MazFSa and subjected
to analysis in a 20% sequencing gel run with an RNA ladder by alkaline hydrolysis as described in Materials and Methods. (A) Cleavage of a synthetic
18-base RNA, AUUC. Lane 1, RNA ladder generated by alkaline hydrolysis; lane 2, RNA substrate without the addition of MazFSa; lane 3, RNA
substrate digested by15 pmol of MazFSa. The corresponding RNA sequence is shown to the right. The cleavage product and site are indicated by arrows.
(B) Cleavage specificity of MazFSa with synthetic 18-base RNA substrates. Seven RNA substrates with the center AUUC sequence were changed to
AGUC, AUGC, GUUG, UUUC, AUUG, GUUC, and AUUU sequences and named correspondingly. The ATTC indicates the same length of DNA
substrate. Lanes 1, 3, 5, 7, 9, 11, 13, 15, and 17 contained no MazFSa; lanes 2, 4, 6, 8, 10, 12, 14, 16, and 18 are with 15 pmol of MazFSa added. The
background in the absence of MazFSa was attributed to impurities or incomplete synthesis of the full-length RNA substrates. Nevertheless, cleavage can
be seen with MazFSa, as indicated by the arrows. (C) Predicted secondary structure formed by RB-1 (5-UGCAAUUCAUAUGAAUUGU-3) using the
RNA secondary prediction website (http://www.genebee.msu.su/services/rna2_reduced.html). (D) Cleavage of highly purified synthetic RNA substrates
with different secondary structures. An 18-base sense RNA, AUUC, and AUUC antisense RNA RB-3, were digested separately by MazFSa. The 19-base
RNAs RB-1 and RB-2 (an RB-1 variant) were also digested with MazFSa. Lanes 2, 4, 6, and 8 are with no MazFSa addition; lanes 3, 5, 7, and 9 are with
15 pmol of MazFSa added. The cleavage products are indicated by arrows. (E) Effects of RNA-RNA duplex formation on cleavage by MazFSa. Lane 1,
RNA ladder generated by alkaline hydrolysis; lane 2, labeled sense RNA alone; lane 3, labeled sense RNA digested with 15 pmol of MazFSa; lanes 4 to
7, the labeled 18-base sense RNA, AUUC, was annealed with AUUC antisense RNA RB-3 in ratios of 1: 0.2, 1:0.4, 1:0.8, and 1:1, respectively, as
indicated and then digested with 15 pmol of MazFSa at 37°C for 30 min.
TABLE 1. ctpA mRNA sequences around cleavage sites






a The cleavage sites in the ctpA mRNA were determined by in vitro primer
extension with primers pEa, pEb, and pEd (Fig. 4). The sequences around the
MazFsa cleavage sites are indicated by bold characters, and the cleavages are
indicated by arrows.
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Seven additional 18-base synthetic RNA substrates were syn-
thesized with the AUUC sequence in the center being replaced
by AGUC, AUGC, AUUU, AUUG, GUUC, GUUG, or
UUUC to examine consensus residues in VUUV (Fig. 5B).
Our analyses showed that both U residues are essential for
cleavage to occur; alterations in any of the two U residues in
the center of the consensus sequence completely abolished the
cleavage by MazFSa (Fig. 5B, lanes 4 and 6). The cleavage
efficiency was reduced significantly if the first and the fourth
residues were changed to U (Fig. 5B, lanes 10 and 16). The
fourth C residue could be changed to G without any significant
loss of cleavage efficiency (Fig. 5B, lane 12). The first A could
be changed to G with some degree of reduced cleavage effi-
ciency (Fig. 5B, lanes 8 and 14). No cleavage occurred with the
corresponding single-stranded DNA sequence (Fig. 5B, lane
18), indicating that MazFSa specifically cleaves RNA. There
was clear cleavage with the sequences AUUA and CUUA in
the ctpA mRNA template, as shown in Fig. 4C and D. These
results confirm that MazFSa is an endoribonuclease that spe-
cifically cleaves the consensus RNA sequence VUUV.
There are other VUUV sequences present in the ctpA
mRNA, but cleavage did not occur with these sequences. We
speculate that secondary structures of the substrate may affect
the cleavage by MazFSa. To test this, a highly purified 19-base
synthetic RNA, RB-1, which can form a hairpin structure with
the AUUC sequence embedded within the stem region (Fig.
5C), was digested with MazFSa. Cleavage was completely
blocked with this hairpin structure, whereas clear cleavage
occurred with the purified RB-2, the synthetic RNA without
the hairpin structure that encompassed the AUUC sequence
(Fig. 5D, lanes 5 and 7). We next examined the cleavage of
MazFSa on the AUUC antisense RNA, RB-3. Although there
was an AUUG sequence in the single-stranded AUUC anti-
sense RNA, cleavage by MazFSa did not occur (Fig. 5D, lane
9), whereas the altered sense-strand RNA with the AUUG
sequence (Fig. 5B, lane 12) was efficiently cleaved by MazFSa.
The reason for this discrepancy is unknown, but it is conceiv-
able that the sequences adjacent to VUUV may play a role in
promoting cleavage. The cleavage by MazFSa was also blocked
when the sense RNA with the AUUC sequence annealed with
its antisense-strand RNA, RB-3, to form an RNA-RNA duplex
in a dose-dependent manner (Fig. 5E). These results suggested
that MazFSa cannot cleave the VUUV sequences in the RNA-
RNA duplex and hence is only specific for single-stranded
RNA without any intramolecular base pairing involving
VUUV.
In vivo cleavage of ctpA RNA by MazFSa. To determine the
MazFSa-specific cleavage sites in mRNA in vivo, primer exten-
sion analysis of ctpA mRNA was performed with total RNA
extracted from both E. coli and S. aureus carrying the corre-
sponding plasmids at various time points after induction as
described in Materials and Methods. A clear in vivo cleavage
site was determined in E. coli with primer pEa, as shown in Fig.
6A. A primer extension product appeared at 30 min after
induction of MazFSa, with subsequent time points showing
cleavage in a time-dependent manner (lanes 2 to 5). However,
the effect of MazFSa in E. coli likely occurs within seconds of
initiation of the reaction, as this extension product can almost
be detected at time zero (Fig. 6A, lane 1). In vivo cleavage was
also detected in S. aureus 178RI carrying plasmid pG164-
MazF(His)6/ctpA with primer pEa (Fig. 6B), but the cleaved
ctpA mRNA with the extension product was faintly detected
only after 30 min of induction (Fig. 6B). We speculate this may
be due to a lower copy number of the cotranscribed ctpA
mRNA. Nevertheless, the cleavage recognition site in vivo in
both E. coli and S. aureus (Fig. 6A and B) was found to be
identical to the one in vitro (Fig. 4A), but the cleavage site was
shifted two bases upstream. Collectively, these results indi-
cated that MazFSa recognizes the same site on ctpA mRNA
both in vivo and in vitro, but the exact cleavage site may differ
by one to two bases between those in vivo and in vitro, which
could be due to trimming of the RNA ends by cellular RNases.
Environmental stress triggers increasing expression of the
mazEFSa transcript. The mazEFSa operon is located upstream
of the sigB operon and is cotranscribed as a 3.6-kb transcript
(Fig. 1A). This genetic arrangement suggests that mazEFSa
may be related to environmental stresses. We thus examined
the transcription of mazEFSa upon exposure to antibiotics.
Increased expression of a 3.6-kb and a 0.5-kb transcript, as
estimated from the migration pattern and corresponding to the
FIG. 6. In vivo cleavage of ctpA mRNA after induction for MazFSa expression. Expression of MazFSa in E. coli BL21(DE3)pLysS carrying
plasmids pET14b-ctpA and pBAD-MazF(His)6 was induced by arabinose (0.2%) (A). The expression of MazFSa in S. aureus 178RI carrying
plasmid pG164-MazF(His)6/ctpA was induced by 1 mM IPTG (B). Total cellular RNAs were extracted at the indicated time points. Primer
extension was then carried out as described in Materials and Methods. The DNA sequencing ladder was prepared using the same primer. The
cleavage sites in the ctpA mRNA are indicated by arrows. The two panels represent in vivo primer extension with primer pEa from E. coli and S.
aureus, respectively.
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cotranscript with the sigB operon and the transcript of the
mazEFSa operon alone (Fig. 1A), respectively, was detected
with the mazEFSa probe upon exposure to doxycycline (DOX)
for 45 min (Fig. 7). The increase of both transcripts was also
found with exposure to sub-MIC levels of other antibiotics,
e.g., erythromycin and penicillin (unpublished data). Interest-
ingly, no reduction in CFU counts was observed with exposure
to antibiotic at sub-MIC levels (data not shown). Similarly, we
also found brief exposure of S. aureus cells to heat (48°C)
activated transcription of the mazEFSa promoter (unpublished
data), thus confirming the finding of Senn et al., who also
demonstrated increased transcription of mazEFSa with sigB
upon heat stress treatment (30). This is different from the
mazEF system in E. coli, wherein brief exposure of antibiotic or
heat disrupts mazEF transcription and translation, thus leading
to proteolysis of the labile MazE and hence unleashing the
endoribonuclease activity of MazF (1, 15, 29). This mode of
action of MazF in E. coli has been termed programmed cell
death by one group of investigators (9), but this claim has been
disputed in studies presented by Tsilibaris et al. (33).
DISCUSSION
Staphylococcus aureus is a major opportunistic pathogen that
is a leading cause of nosocomial infections associated with
surgical wounds and indwelling medical devices. Despite anti-
microbial therapy, the morbidity and mortality associated with
S. aureus infections remain high, due in part to the organism’s
ability to develop resistance to antibiotics, including that to
vancomycin (5, 20). In searching for antimicrobial targets
within the stress-induced operon, we noticed, as did Kullik et
al. (18), that the ORF (SA2058) upstream of rsbU, the first
gene within the established sigB operon, shares sequence sim-
ilarity with mazF of E. coli. Given that mazE and mazF in
prokaryotes are often cotranscribed, we were puzzled with the
functional identity of these two ORFs, since SA2059, directly
upstream of SA2058, has little homology with mazE of E. coli.
In S. aureus, SA2059 and SA2058 have been shown to co-
transcribe with the sigB operon, particularly under stressful
conditions (30). Given that both mazEF and the sigB operons
are modulated under stress and that SA2058 is homologous
with mazF of E. coli, it is reasonable to speculate that SA2058
and SA2059 may represent a MazEF-like system in S. aureus,
despite a lack of supporting experimental data. In this study,
we demonstrated that MazEFSa of S. aureus is a TA module
wherein MazFSa is the toxin and MazESa is the antitoxin that
binds MazFSa to inhibit its toxicity. Our data showed that
MazFSa is toxic to both E. coli and S. aureus after induction for
its expression (Fig. 1). It inhibits protein synthesis in a cell-free
system by cleaving mRNA substrates. MazESa, on the other
hand, inhibits the toxicity of MazFSa by preventing cleavage of
the target mRNA and hence releases the inhibition in protein
synthesis by MazFSa (Fig. 2 and 3). This inhibition was due to
the formation of the MazESa/MazFSa complex (Fig. 1D), which
prevents the free form of MazFSa from cleaving the target
RNA (Fig. 3B). However, the exact stoichiometry by which the
C-terminal arm of MazESa mimics the similarly charged sugar-
phosphate backbone of RNA to inhibit MazFSa toxin activity
by occupying the RNA binding site on the MazFSa toxin as
described for E. coli (19) will require further detailed crystal
structure studies of the MazE/MazFSa complex.
In S. aureus and some gram-positive bacteria (e.g., B. subtilis
and Listeria monocytogenes), mazEF homologs are located im-
mediately upstream of the sigB operon, which encodes 
B, the
main alternative transcription factor involved in the stress re-
sponse of many gram-positive bacteria, and a series of anti-
sigma factors to control the concentration of free 
B (10, 13,
27, 30). In contrast, the mazEF genes in E. coli are located
downstream of the relA gene. relA encodes a synthase for
ppGpp and is upregulated in response to uncharged tRNA at
the ribosomal A-site during amino acid starvation and other
stressful conditions, including antibiotic exposure (1, 15, 29). It
was shown that overproduction of ppGpp (by overproducing
RelA, a truncated version of ppGpp synthetase I of E. coli) in
a strain derived from MC4100 represses expression from the
mazEF promoter. Those authors then suggested that physio-
logical conditions that confer increased levels of ppGpp would
reduce synthesis of MazE antitoxin, hence enabling degrada-
tion of the more labile MazE antitoxin by the ClpPA protease
system and unleashing the toxic effect of MazF to execute
programmed cell death (PCD) (1). However, Christensen et al.
(6) investigated whether the transcription pattern of mazEF
during amino acid starvation induced by serine hydroxamate
was stimulated strongly by amino acid starvation, and this
stimulation depended on Lon. No TA locus-dependent cell
killing was observed during this amino acid starvation. Penersen
et al. (25) also showed that the toxicity of MazF in E. coli
can be rescued by the antitoxin MazE, expressed within 6 h
after MazF induction. They further proposed that MazF does not
mediate cell killing but rather induces a bacteriostatic condi-
tion. Both studies have shed doubt on the notion of PCD
proposed by Aizenman et al. (1). Indeed, even with the over-
production of MazF, E. coli cells can retain transcriptional and
translational competence for 4 days despite their growth arrest
(31). Although Sat et al. (29), Amitai et al. (2), and Hazan et
al. (15) suggested PCD is mediated by mazEF from E. coli
upon exposure to some antibiotics, controversial results were
presented for the same PCD experiments by Tsilibaris et al.
(33); thus, the physiological roles of the toxin proteins remain
under debate.
Our results demonstrated that the expression of the
mazEFSa transcripts was up-regulated (Fig. 7) when the culture
was exposed to sub-MIC levels of some antibiotics, with no
great loss of cell viability. Given the divergent structural ar-
FIG. 7. DOX stress induced increasing expression of mazEFSa
transcripts. The S. aureus Newman culture was treated with 50 ng/ml
DOX at optical density at 650 nm of 1.0. Total cellular RNAs were
extracted at the indicated time points. Northern blot analysis was
carried out with the mazEFSa probe as described in Materials and
Methods. (A) Transcripts detected with the probe. (B) 23S and 16S
served as the internal loading control.
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rangement between E. coli and S. aureus with respect to
MazEF and the stress operon, the regulation of the S. aureus
MazEFSa TA module in response to stress warrants additional
investigation (unpublished data). Pedersen et al. (25) reported
that RelE-induced cell stasis exhibited increased sensitivity
towards environmental stresses, e.g., heat shock, oxygen radi-
cals, and osmotic stress. The above studies have led to the
suggestion that TA complexes might constitute a novel ap-
proach toward the potential development of a new class of
antimicrobial compounds which activate or mimic bacterial
toxins. Compounds could function through several different
mechanisms, such as preventing or reducing the association
between a given TA pair or manipulating the signaling pathway
that leads to toxin activation (9, 12, 22).
As with E. coli MazF, the MazFSa of S. aureus was also found
to be a ribosome-independent endoribonuclease, but with very
different sequence specificity compared with other MazF ho-
mologs. In particular, it cleaves the RNA substrate in a U-rich
region with the consensus sequences VUUV as demonstrated
both in vivo and in vitro (Fig. 4 and 5). Most commonly, the
cleavage sites reside in the 5 end of the first U residue and at
the 3 end of the second U (Fig. 4; Table 1). Importantly, the
two U residues are essential for the MazFSa cleavage, since
replacement of either U residue abolishes the cleavage while
the V and V residues can be A, C, and G. When V or V
residues were changed to U, the cleavage efficiency was signif-
icantly reduced (Fig. 5). Previously, the MazF of E. coli was
demonstrated to cleave RNA substrates specifically at the 5
end of ACA sequences (34). Similarly, two MazF homologs
from Mycobacterium tuberculosis were also found to cleave at
UAC triplets and (U/C)U2(A/U)C(U/C) in the mRNA (39).
Another PemK family toxin, EndoA from Bacillus subtilis,
which shares homology with MazF of E. coli, was also shown to
cleave at a UAC sequence (27). These results suggest that the
cleavage sites of different MazF homologs in prokaryotes can
differ. In particular, MazFSa is the first example of a toxin that
cleaves most commonly at the 5 or 3 end an invariant UU
residue with a consensus sequence of VUUV. How various
toxins contribute to bacterial cell physiology and metabolism in
response to stress by cleaving mRNAs at specific sites is of
general interest and merits further studies.
As there are other VUUV sequences within the ctpA
mRNA that are not amenable to cleavage, we investigated the
role of the secondary structure of RNA, including the stem-
loop structure and RNA duplex, in mRNA cleavage by
MazFSa. Our data clearly showed that the VUUV sequence
can be cleaved as part of a loop, but not as part of the stem
where the VUUV sequence may form a partial RNA duplex
(Fig. 5C and D). To confirm this, we incubated MazFSa with a
perfect RNA-RNA duplex where the antisense RNA was com-
plementary to the sense RNA strand, which is amenable to
cleavage under in vitro conditions. As predicted from the stem-
loop study and in concordance with the data for the MazF of
E. coli (37), MazFSa can only cleave the single-stranded RNA
at the predicted VUUV site but not the perfect RNA-RNA
duplex (Fig. 5E). Curiously, the MazFSa toxin cannot cleave
the complementary antisense RNA strand with the 5-GAAU
UG-3 sequence, where the first four bases are complementary
to the AUUC consensus sequence in the sense strand and the
last four nucleotides constitute the putative AUUG cleavage
site (see the description of the AUUC antisense RB-3 in Ma-
terials and Methods). The reason for the difference in cleavage
between the sense and the AUUC antisense strand is not
entirely clear, but it may be due to the secondary structure, or
the adjacent sequence may contribute to recognition of the
putative site. Our data also demonstrated that MazFSa recog-
nizes the same site on ctpA mRNA both in vivo and in vitro,
but the exact cleavage site differed by one to two bases (Fig. 6).
These differences may be due to changes in the buffering en-
vironment, which could affect the folding of the ctpA mRNA
substrate. It is also quite possible that there may be another
protein interacting with MazFSa besides MazESa, which could
change the conformation of this endoribonuclease, or that the
RNA ends may be trimmed by RNases in vivo.
Recently, Moritz and Hergenrother showed that the mazEF
TA system was found to be ubiquitous among plasmids ob-
tained from vancomycin-resistant enterococci (22). Consistent
with the early discovery of TA system in plasmids (11, 24), they
proposed that the MazEF system functions to stabilize the
plasmid in Enterococcus species. Since the vanA gene, the
critical component of vancomycin resistance in enterococci
(22), resides on the same plasmid as that of the mazEF genes
in over 90% of the strains, this raises the possibility that TA
systems may also serve to maintain the vancomycin-resistant
gene in Enterococcus species. Given that gene transfer has
been shown to occur between staphylococci and enterococci, it
remains to be seen if the MazEFSa system plays an important
role in maintenance of antibiotic resistance genes in S. aureus.
Although the MazFSa toxin shares sequence similarity to its
counterparts in E. coli and B. subtilis, the antitoxin MazESa was
found to be homologous to MazE-like molecules only in Staph-
ylococcus epidermis, Staphylococcus hemolyticus and Staphylo-
coccus saprophyticus, but not to other paralogs in gram-positive
species (e.g., YdcD in B. subtilis). Studies in another TA mod-
ule called yefM/yoeB in Streptococcus pneumoniae showed that
the toxicity of YoeB could be reverted by its cognate antitoxin
YefM, but not by the YefM homolog from E. coli (23). The
above findings clearly indicate that antitoxins are different be-
tween species within the same TA systems, while the toxins are
more homologous.
Collectively, our findings indicate that the MazFSa of S.
aureus differs in cleavage specificity from its E. coli counter-
part. Based on the arrangement of mazEFSa together with the
sigB operon as a single transcription unit and that the sigB
operon is a known stress-induced transcription unit, we spec-
ulate that the toxic effect of MazFSa for S. aureus in response
to stress likely diverges from that of E. coli. Finally, genomic
mining reveals that MazESa may be unique in staphylococcal
species. Accordingly, we predict that a successful anti-MazESa
strategy will be active against other staphylococcal species as
well.
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